Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.

FDA approves new migraine prevention drug

Aimovig works by blocking the molecule CGRP, which in high levels can cause the body to feel more pain — migraine sufferers often have high levels of it.

Best of NBC News

Play All